The Glassware Core Facility provides Cancer Center laboratory researchers with clean and sterile glassware for cell culture, molecular biology and biochemistry experiments. In addition to washing and sterilizing glassware for individual laboratories, this facility washes, sterilizes and delivers glass bottles to the Bioreagents and Cell Culture Core Facility for preparation of sterile culture media. The Core also prepares double-deionized and distilled water in large quantities for use in the preparation of reagents and sterilizes pipettes for molecular biology experiments. The Core Facility is located at three sites: the Norris building, the Cancer Research Laboratory (CRL), and the Smith Research Tower at Childrens Hospital Los Angeles (CHLA). The 1,300 sq. ft. Norris space contains two automatic dishwashers, two autoclaves, and a drying oven. The CRL houses a dishwasher and an autoclave in 1,000 sq. ft. The CHLA space has an autoclave and dishwashing facilities. The Glassware Core Facility serves 54 Cancer Center members and their research groups, approximately 350 scientists and technical staff in total. The CCSG supports 4.5 FTE glassware technicians and one is supported by chargebacks. The Glassware Core Facility is supervised by Joseph Landolph, Ph.D., Associated Professor of Molecular Microbiology and Immunology. Mr. Bill Taylor, Director of General Services, is the manager of the daily operations at Norris and CRL. The glassware services at CHLA are overseen by Dr. Ambrose Jong, Ph.D., Associate Professor of Pediatrics and Molecular Microbiology and Immunology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014089-27
Application #
6563666
Study Section
Project Start
2001-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
27
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
Liu, Minmin; Zhang, Lian; Li, Hongtao et al. (2018) Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI-110) in Hepatocellular Carcinoma. Hepatology 68:1412-1428
Miller, Kimberly A; Ramirez, Cynthia N; Wojcik, Katherine Y et al. (2018) Prevalence and correlates of health information-seeking among Hispanic and non-Hispanic childhood cancer survivors. Support Care Cancer 26:1305-1313
Belic, Jelena; Graf, Ricarda; Bauernhofer, Thomas et al. (2018) Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide. Int J Cancer 143:1236-1248
Tobin, Jessica; Allem, Jon-Patrick; Slaughter, Rhona et al. (2018) Posttraumatic growth among childhood cancer survivors: Associations with ethnicity, acculturation, and religious service attendance. J Psychosoc Oncol 36:175-188
Schaal, Justin B; Maretzky, Thorsten; Tran, Dat Q et al. (2018) Macrocyclic ?-defensins suppress tumor necrosis factor-? (TNF-?) shedding by inhibition of TNF-?-converting enzyme. J Biol Chem 293:2725-2734
Iriondo, Oihana; Liu, Yarong; Lee, Grace et al. (2018) TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis. Nat Commun 9:1994
Robison, Nathan J; Yeo, Kee Kiat; Berliner, Adrian P et al. (2018) Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors. J Neurooncol 138:199-207
Naseem, Madiha; Barzi, Afsaneh; Brezden-Masley, Christine et al. (2018) Outlooks on Epstein-Barr virus associated gastric cancer. Cancer Treat Rev 66:15-22
Sebio, A; Stintzing, S; Heinemann, V et al. (2018) A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials. Pharmacogenomics J 18:43-48
Peres, Lauren C; Risch, Harvey; Terry, Kathryn L et al. (2018) Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol 47:460-472

Showing the most recent 10 out of 842 publications